Belimumab
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Belimumab and local guidelines before prescribing.
Biologic (anti-BLyS)
Mechanism
Anti-BLyS monoclonal antibody inhibiting B-cell survival.
Uses
Active SLE, lupus nephritis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Infections, infusion reactions, depression, nausea.
Interactions
Live vaccines contraindicated.
Contraindications and cautions
Active severe infection
Monitoring
Disease activity, mood
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
No adjustment
Overdose and reversal
Supportive
Special advice
Monitor mood; not for severe CNS lupus.
More from the textbook: uses, cautions and other points
- Add-on options - voclosporin (with MMF; NICE TA882) or belimumab .
Renal: Glomerular Disease - Belimumab | Anti-BLyS add-on for lupus nephritis.
Renal: Glomerular Disease - Class III/IV: steroids with MMF (or low-dose cyclophosphamide); consider voclosporin or belimumab.
Renal: Glomerular Disease - BAFF / type I IFN receptor | Belimumab / anifrolumab | SLE
Rheumatology Anatomy Physiology Pharmacology - BLyS / BAFF | Belimumab | SLE including nephritis | Infections, depression
Rheumatology: assessment, investigations and drugs - Induction - steroids (IV methylprednisolone pulses then oral) plus mycophenolate or low-dose IV cyclophosphamide (Euro-Lupus); add belimumab or a calcineurin inhibitor (voclosporin, tacrolimus) in many patients.
Rheumatology: Connective tissue diseases - Moderate disease - steroid-sparing immunosuppressants - methotrexate (joints and skin), azathioprine, mycophenolate; belimumab or anifrolumab for persistent activity (NICE TAs).
Rheumatology: Connective tissue diseases - SLE | Malar rash, arthritis, serositis, nephritis, cytopenias | ANA, anti-dsDNA, anti-Sm; low C3/C4 | Hydroxychloroquine for all; steroids, MMF, belimumab
Rheumatology: Connective tissue diseases
Where it is discussed in the book
- Renal: Glomerular Disease (3 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (1 mention)
- Rheumatology: Connective tissue diseases (4 mentions)
- Clinical Immunology: Autoimmunity, autoantibodies and complement (2 mentions)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (1 mention)